Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer.

Oncotarget · 2015 · PMC4694916 · PMID 26317899

Europe PMC DOI

hedged sentence

0.0645

closest p · 1.3× alpha

0.0645

boldest claim

The sentences

did not reach statistical significancep < 0.0645so close (0.05 < p ≤ 0.1)

PD-L2 expression was also elevated in the presence of the PDJ amplicon however it did not reach statistical significance ( p < 0.0645) in this preliminary study.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.